Persodia Research
IVD Industry Structural Repository
ivd industry, structured
Following the book "Inside Clinical Diagnostics Industry"
Operational Architecture
Infrastructure Irreversibility
Installed systems, facilities, and automation create high switching costs and limit future strategic flexibility.
Operational Architecture
Capital Embedding
Capital becomes locked in long-lifecycle assets, reducing redeployability and increasing financial rigidity.
Company Architecture
Regulated Portfolio Inertia
Expanding portfolios accumulate regulatory burden, making simplification slow, costly, and operationally constrained.
- Inside Clinical Diagnostics Industry
- Product Portfolio Optimization
Company Architecture
Scale Reconfiguration
Growth triggers structural resets in manufacturing, organization, and cost base before efficiency stabilizes.
Market Interface
Downstream Mediation
Execution depends on external actors controlling workflow, reducing direct control over adoption and value realization.
Market Interface
Partnership Asymmetry
Strategic partners hold unequal power, shifting control, margins, and long-term strategic flexibility away from the firm.
- Inside Clinical Diagnostics Industry
- Leveraging Partnerships
System Environment
Market Access Gatekeeping
Reimbursement and payer systems determine adoption pace, regardless of technical or clinical performance.
- Inside Clinical Diagnostics Industry
- Excelling Market Access
System Environment
Evidence Escape
Clinical validation depends on external institutions, limiting control over evidence generation and value recognition.
- Inside Clinical Diagnostics Industry
- Earning Clinical Authority